Home › Funds › Eagle Health Investments LP › REPL
Eagle Health Investments LP position in REPL
REPLIMUNE GROUP INC · Health Care
Eagle Health Investments LP reported holding 724,787 shares of REPL (REPLIMUNE GROUP INC) in its Q3 2026 13F filing — a position valued at US$9.6M, representing 1.73% of its reported portfolio and ranking #19 among its reported holdings. Eagle Health Investments LP first reported this position in Q3 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Eagle Health Investments LP's REPL position evolved
Eagle Health Investments LP first disclosed a stake in REPL in Q3 2026 at 724,787 shares (US$9.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 724.79K | $9.60M | New |
About REPL and 13F data
REPL (REPLIMUNE GROUP INC) is a Health Care company. 40 other funds we track also report a position in REPL — the largest reported positions include BAKER BROS. ADVISORS LP (US$122.3M), RTW INVESTMENTS, LP (US$82.0M), Ridgeback Capital Investments L.P. (US$80.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding REPL
- BAKER BROS. ADVISORS LP 11.05M sh · $122.27M · Q2 2026
- RTW INVESTMENTS, LP 7.41M sh · $82.05M · Q2 2026
- Ridgeback Capital Investments L.P. 7.31M sh · $80.93M · Q2 2026
- MONTANOVA CAPITAL, LLC 4.39M sh · $48.60M · Q2 2026
- Boxer Capital Management, LLC 3.98M sh · $44.09M · Q2 2026
- FCPM III SERVICES B.V. 2.81M sh · $31.09M · Q2 2026
- Logos Global Management LP 2.50M sh · $27.68M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 1.60M sh · $21.23M · Q3 2026
- Opaleye Management Inc. 1.38M sh · $15.33M · Q2 2026
More on Eagle Health Investments LP
FAQ
How long has Eagle Health Investments LP held REPL?
Eagle Health Investments LP has disclosed REPL holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Eagle Health Investments LP's current position in REPL?
As of Q3 2026, Eagle Health Investments LP holds 724.79K shares of REPL (REPLIMUNE GROUP INC), valued at $9.60M, representing 1.73% of its reported portfolio and ranking #19.
Has Eagle Health Investments LP been buying or selling REPL?
In the latest 13F filing (Q3 2026), Eagle Health Investments LP newly opened its position in REPL.
Which other funds hold REPL?
Other major institutional holders of REPL include BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, Ridgeback Capital Investments L.P., among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.